Patent application number | Description | Published |
20110269418 | RF Performance Improvement - A method is disclosed that includes measuring, under control of one or more processors of a mobile device, performance of a radio frequency reception parameter for radio frequency reception for the mobile device. The mobile device includes one or more antennas over which the radio frequency reception occurs and the one or more processors. The method includes causing movement of the mobile device to improve the performance of the radio frequency reception parameter. A mobile device includes one or more antennas over which radio frequency reception occurs, one or more processors, and one or more memories including computer program code. The mobile device performs at least the following: measuring, under control of the one or more processors, performance of a radio frequency reception parameter, and causing movement of the mobile device to improve the performance of the a radio frequency reception parameter. Program products are also disclosed. | 11-03-2011 |
20140126751 | Multi-Resolution Audio Signals - An apparatus including at least one microphone; audio circuitry connected to the at least one microphone; and a memory connected to the audio circuitry. The audio circuitry is configured to output a first audio track and at least one second audio track. The audio circuitry is configured to form the first audio track from an output signal, provided by the at least one microphone, by processing the output signal with a first audio configuring, and where the audio circuitry is configured to form the at least one second audio track from the output signal, provided by the at least one microphone, without the first audio configuring. The memory is configured to store the first audio track and the at least one second audio track together. | 05-08-2014 |
Patent application number | Description | Published |
20090181004 | MODIFIED BETA-LACTAMASE AND METHOD FOR ITS PREPARATION - The invention relates to targeted post translational modifi-cation of metallo-beta-lactamase by truncation and inser-tion of a dipeptide at the amino terminal end to reduce amino terminal heterogeneity in a recombinant DNA pro-duction system. A protein K-T-E-ΔBL is expressed, and modified by host proteases to E-ΔBL. Appropriate nucleotide molecules, vectors and hosts are also de-scribed. E-ΔBL is useful in a pharmaceutical composition for treating antibiotic induced adverse effects in the intes-tine of patients treated with beta-lactam antibiotics. | 07-16-2009 |
20090311234 | USE OF BETA-LACTAMASE - Class A beta-lactamase may be used for reducing side-effects in the intestine associated with antibiotic therapy with a combination of beta-lactam antibiotic and beta-lactamase inhibitor. | 12-17-2009 |
20130216622 | MODIFIED BETA-LACTAMASES AND METHODS AND USES RELATED THERETO - The present invention relates to pharmaceuticals and modified beta-lactamases. Specifically, the invention relates to novel recombinant beta-lactamases and pharmaceutical compositions comprising the beta-lactamases. Also, the present invention relates to methods for modifying a beta-lactamase, producing the beta-lactamase and treating or preventing beta-lactam antibiotic induced adverse effects. Furthermore, the present invention relates to the beta-lactamase for use as a medicament and to the use of the beta-lactamase in the manufacture of a medicament for treating or preventing beta-lactam antibiotics induced adverse effects. | 08-22-2013 |
20140127785 | MODIFIED BETA-LACTAMASES AND METHODS AND USES RELATED THERETO - The present invention relates to pharmaceuticals and modified beta-lactamases. Specifically, the invention relates to novel recombinant beta-lactamases and pharmaceutical compositions comprising the beta-lactamases. Also, the present invention relates to methods for modifying a beta-lactamase, producing the beta-lactamase and treating or preventing beta-lactam antibiotic induced adverse effects. Furthermore, the present invention relates to the beta-lactamase for use as a medicament and to the use of the beta-lactamase in the manufacture of a medicament for treating or preventing beta-lactam antibiotics induced adverse effects. | 05-08-2014 |
20150056178 | MODIFIED BETA-LACTAMASES AND METHODS AND USES RELATED THERETO - The present invention relates to pharmaceuticals and modified beta-lactamases. Specifically, the invention relates to novel recombinant beta-lactamases and pharmaceutical compositions comprising the beta-lactamases. | 02-26-2015 |
20150209418 | MODIFIED BETA-LACTAMASES AND METHODS AND USES RELATED THERETO - The present invention relates to pharmaceuticals and modified beta-lactamases. Specifically, the invention relates to novel recombinant beta-lactamases and pharmaceutical compositions comprising the beta-lactamases. Also, the present invention relates to methods for modifying a beta-lactamase, producing the beta-lactamase and treating or preventing beta-lactam antibiotic induced adverse effects. Furthermore, the present invention relates to the beta-lactamase for use as a medicament and to the use of the beta-lactamase in the manufacture of a medicament for treating or preventing beta-lactam antibiotics induced adverse effects. | 07-30-2015 |
Patent application number | Description | Published |
20100152548 | MEASUREMENT DEVICE, SYSTEM AND METHOD - A user portable measurement device ( | 06-17-2010 |
20110263331 | DEVICE, SYSTEM AND METHOD FOR MEASUREMENT OF PHYSICAL ACTIVITY - A device, system and method for measuring physical activity, especially applicable for monitoring and inspiring physical exercise of e.g. children and adolescents. The prior art devices appear to lack the inspiring effect especially when children and adolescents are concerned. The object is achieved with a solution in which a portable exercise measurement device of a user has elements for transferring data with another measurement device and/or with a location indicating device and/or with another mobile device. The data transfer is based on short range communication, such as Bluetooth, Near Field Communication (NFC) or Radio Frequency Identification Device (RFID) technology. The device facilitates interactive playing which includes physical exercise. | 10-27-2011 |
20130324823 | MEASUREMENT DEVICE, SYSTEM AND METHOD - The object of the invention is a measurement device and a system for measuring and monitoring information which relates to diabetes care. The purpose of the invention is to motivate a user to perform activities that are required in the care. In a preferred embodiment of the invention a performance levels are determined and the level of a user is based on the activities and/or measurement results of the user. Upon increase in the user's level the user is awarded with e.g. new reminder figure in the device. The motivation of a user to follow care activities is thus increased. | 12-05-2013 |
20130331659 | USER INTERFACE OF A MEASUREMENT DEVICE AND SYSTEM - The object of the invention is a user interface for a device and a system for measuring and monitoring information which relates to diabetes care. The purpose of the invention is to facilitate and motivate a user to perform activities that are required in the care. In a preferred embodiment of the invention user specific information is stored in the measurement device with a user interface, such as a menu-based graphical user interface. The user may input performed activities through the user interface, and to store user's own figurative or sound data to be used by the user interface. The user interface may provide automatically suggestions for a user regarding the input. | 12-12-2013 |
20140311227 | PORTABLE DEVICE FOR MEASURING BLOOD SAMPLES - The invention relates to a device for measuring and monitoring glucose content of blood. The invention is especially applicable for users with diabetes disease. In a device of the present invention sample input aperture ( | 10-23-2014 |
20150083590 | PORTABLE DEVICE ASSEMBLY FOR MEASURING BLOOD SAMPLES AND A DEVICE COVER - A device assembly for measuring and monitoring glucose content of blood, and a cover of such an assembly. The assembly is especially applicable for users with diabetes disease. The assembly includes a resilient cover on a measurement device. The cover has a slit at the input for a blood sample strip. The slit is closed at its rest position, but a test strip can be entered through the slit based on the resilience of the cover material. The resilient cover absorbs possible mechanical impacts and prevents impurities from reaching the sensor electronics. | 03-26-2015 |